REED GASTROINTESTINAL ONCOLOGY RESEARCH FOUNDATION (EIN 820565754) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Legal Domicile

Principal Officer

SCOTT REED

Phone

2052634702

Tax Period

2023-01-01 to 2023-12-31

REED GASTROINTESTINAL ONCOLOGY RESEARCH FOUNDATION, founded in 2002, is a small nonprofit in the Medical Research sector that reported $249K in total revenue in fiscal year 2018. Revenue decreased 10% compared to the prior year. Net assets of $723K represent 35 months of operating reserves.

Mission

THE FOUNDATION SUPPORTS CANCER RESEARCH ACTIVITIES TO PROMOTE EARLIER DIAGNOSIS, PREVENTION AND EFFECTIVE TREATMENT OF GASTRO-INTESTINAL CANCERS.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $346,709

Program Service Revenue $0

Investment Income $22,367

Other Revenue $-132,919

TOTAL REVENUE $236,157

Expense Breakdown

Grants Paid $0

Salaries & Benefits $86,558

Fundraising Expenses $48,381

Program Expenses $48,618

Other Expenses $141,049

TOTAL EXPENSES $227,607

Year-over-Year Comparison

	2023	2022	Change
Revenue	$236,157	$133,491	+0.8%
Expenses	$227,607	$274,648	-0.2%
Net Income	$8,550	$-141,157	-1.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$75,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SCOTT B REED	DIRECTOR	1.00	Officer Director	$0	$0	$0
MARTIN J HESLIN MD	DIRECTOR	1.00	Officer Director	$0	$0	$0
ROBERT A REED	DIRECTOR	1.00	Officer Director	$0	$0	$0
CAROLYN B REED	DIRECTOR	1.00	Officer Director	$0	$0	$0
MARSHALL M URIST MD	DIRECTOR	1.00	Officer Director	$0	$0	$0
HANNON SHARLEY DAVIDSON	EXECUTIVE DIRECTOR	5.00	Officer	$75,000	$0	$75,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$236,157	$227,607	$485,159	$8,550
2022	$133,491	$274,648	$475,834	$-141,157
2021	$334,136	$240,655	$612,655	$93,481
2020	$250,520	$369,274	$519,174	$-118,754
2019	$200,692	$286,187	$637,928	$-85,495
2018	$249,454	$274,275	$723,423	$-24,821

REED GASTROINTESTINAL ONCOLOGY RESEARCH FOUNDATION